Shares of Ascletis Pharma Inc. (OTCMKTS:ASCLF – Get Free Report) rose 10.1% on Friday . The company traded as high as $1.74 and last traded at $1.74. Approximately 7,000 shares changed hands during trading, an increase of 210% from the average daily volume of 2,259 shares. The stock had previously closed at $1.58.
Ascletis Pharma Stock Up 10.1%
The company’s fifty day moving average is $1.37 and its two-hundred day moving average is $1.35.
Ascletis Pharma Company Profile
Ascletis Pharma Inc, a biotechnology company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in Mainland China. The company offers Ritonavir tablet; and ASCLEVIR and GANOVO for the treatment of Hepatitis C virus. It is also developing ASC22 for treating CHB and HIV functional cure; ASC10 for respiratory syncytia virus; ASC10 and ASC11 to treat COVID-19; ASC40, ASC41, ASC42, ASC43F FDC for non-alcoholic steatohepatitis; and ASC42 for the treatment of primary biliary cholangitis.
See Also
- Five stocks we like better than Ascletis Pharma
- Want to Profit on the Downtrend? Downtrends, Explained.
- Five Below and Dollar Tree Earnings Signal a Shopper Shift
- What is a Bond Market Holiday? How to Invest and Trade
- Ulta’s Stock May Be Set for a Glow-Up—20% Upside Ahead?
- Following Congress Stock Trades
- Gates Foundation Sells MSFT Stock—Should Investors Be Worried?
Receive News & Ratings for Ascletis Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ascletis Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
